Cargando…

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

BACKGROUND: In some rheumatic diseases such as systemic lupus erythematosus (SLE), low serum complement (‘hypocomplementaemia’) is a feature of active disease. However, the role of hypocomplementaemia in systemic sclerosis (SSc) is unknown. We sought to determine the frequency, clinical associations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, James, Brown, Zoe, Stevens, Wendy, Sahhar, Joanne, Rabusa, Candice, Zochling, Jane, Roddy, Janet, Walker, Jennifer, Proudman, Susanna M., Nikpour, Mandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075219/ https://www.ncbi.nlm.nih.gov/pubmed/27770830 http://dx.doi.org/10.1186/s13075-016-1147-2

Ejemplares similares

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
por: Moxey, Jayne, et al.
Publicado: (2019)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3
por: Zochling, Jane, et al.
Publicado: (2014)

Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol
por: Calderone, Alicia, et al.
Publicado: (2016)

Myocardial fibrosis and arrhythmic burden in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
por: Ross, Laura, et al.
Publicado: (2022)

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
por: Kerick, Martin, et al.
Publicado: (2022)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Cardiovascular disease in systemic sclerosis - an emerging association?
por: Ngian, Gene-Siew, et al.
Publicado: (2011)

Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management
por: Ross, Laura, et al.
Publicado: (2021)

Determinants of left ventricular structure, filling and long axis function in systemic sclerosis
por: Peverill, Roger E., et al.
Publicado: (2021)

47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022)

The Effect of Body Fat Distribution on Systemic Sclerosis
por: Villanueva-Martin, Gonzalo, et al.
Publicado: (2022)

Risk factors for the development of systemic sclerosis: a systematic review of the literature
por: Abbot, Samuel, et al.
Publicado: (2018)

Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2021)

Endobronchial obstruction in connective tissue diseases: an uncommon but life threatening complication: two case reports
por: Shah, Rushab, et al.
Publicado: (2023)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
por: López-Isac, Elena, et al.
Publicado: (2019)

A survey of Australian rheumatologists’ perspectives of nutrition needs in systemic sclerosis
por: Samm, De-arne A, et al.
Publicado: (2023)

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
por: Nikpour, Mandana, et al.
Publicado: (2011)

Prospective observational cohort study of Health Related Quality of Life (HRQOL), chronic foot problems and their determinants in gout: a research protocol
por: Chandratre, Priyanka, et al.
Publicado: (2012)

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
por: Liu, Yiting, et al.
Publicado: (2017)

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
por: Ingram, Gillian, et al.
Publicado: (2014)

Impact of complement activation on clinical outcomes in multiple sclerosis
por: Keller, Christian W., et al.
Publicado: (2021)

The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6svhm06opcp8jvlh43c4o6ro4o